find the latest legal job
Corporate and Commercial Partner
Category: Corporate and Commercial Law | Location: Adelaide SA 5000
· Full time · Join a leading Adelaide commercial law firm
View details
In-house Legal Counsel & Commercial Lawyers
Category: Corporate and Commercial Law | Location: All Sydney NSW
· Providing lawyers with flexibility and control over when they work, how they work and who they work for.
View details
In-house Legal Counsel & Commercial Lawyers
Category: Corporate and Commercial Law | Location: All Melbourne VIC
· Providing lawyers with flexibility and control over when they work, how they work and who they work for.
View details
Legal Inhouse / Lawyer / Company Secretary
Category: Other | Location: Brisbane QLD 4000
· Fantastic Company · Potential to be Part Time / Flexible Work Pattern
View details
Part Time Risk & Compliance Officer
Category: Other | Location: Brisbane QLD 4000
· Brisbane City · Flexible Part Time Hours
View details
Biotech deal gets pulses racing

Biotech deal gets pulses racing

Andrew Silberberg Arnold Bloch Leibler

Arnold Bloch Leibler and King & Wood Mallesons have negotiated a major share purchase in an Australian biopharmaceutical provider by Celgene Corporation.

Firms: Arnold Bloch Leibler (Mesoblast), Wilson Sonsini Goodrich & Rosati (Mesoblast), King & Wood Mallesons (Celgene), Dechert LLP (Celgene)

Deal: Celgene agreed to purchase 15.3 million ordinary shares in Mesoblast Ltd

Value: A$58.5 million

Area: Capital markets

Key players: ABL commercial partner Andrew Silberberg (pictured) worked on the negotiation alongside senior associate John Kim. Strategic support was provided by managing partner Henry Lanzer and commercial partner Jonathan Wenig.

Deal significance:

The investment by Celgene will inject $58.5 million into Australian-owned Mesoblast Ltd.

Celgene is a biotechnology provider based in the United States, described by Arnold Bloch Leibler partner Andrew Silberberg as “a global leader in regenerative medicine”.

Mesoblast is an ASX-listed firm specialising in the treatment of cardiovascular, inflammatory and oncology conditions.

The deal will allow Celgene to strengthen its development and commercialisation pipeline, according to a statement from Arnold Bloch Leibler.

“This is another great example of international interest in an innovative Australian company,” Mr Silberberg said.

Like this story? Read more:

QLS condemns actions of disgraced lawyer as ‘stain on the profession’

NSW proposes big justice reforms to target risk of reoffending

The legal budget breakdown 2017

Biotech deal gets pulses racing
lawyersweekly logo
Promoted content
Recommended by Spike Native Network
more from lawyers weekly
Nov 23 2017
Education a passion for YL president
Promoted by University of Melbourne. Melbourne Law Masters student Phoebe Blank is successfully j...
Crowd
Nov 23 2017
Anti-radicalisation programs playing ‘second fiddle’ to terrorism laws
Several academics have questioned the balance between Australia’s counterterrorism legislation and...
 William Ah Ket
Nov 23 2017
‘Bamboo ceiling’ thought piece wins inaugural law prize
A paper that explores the idea of affirmative action to achieve greater diversity among members of A...
APPOINTMENTS
Allens managing partner Richard Spurio, image courtesy Allens' website
Jun 21 2017
Promo season at Allens
A group of lawyers at Allens have received promotions across its PNG and Australian offices. ...
May 11 2017
Partner exits for in-house role
A Victorian lawyer has left the partnership of a national firm to start a new gig with state governm...
Esteban Gomez
May 11 2017
National firm recruits ‘major asset’
A national law firm has announced it has appointed a new corporate partner who brings over 15 years'...
opinion
Nicole Rich
May 16 2017
Access to justice for young transgender Australians
Reform is looming for the process that young transgender Australians and their families must current...
Geoff Roberson
May 11 2017
The lighter side of the law: when law and comedy collide
On the face of it, there doesn’t seem to be much that is amusing about the law, writes Geoff Rober...
Help
May 10 2017
Advocate’s immunity – without fear or without favour but not both
On 29 March 2017, the High Court handed down its decision in David Kendirjian v Eugene Lepore & ...